ACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis-induced macrophage death.

TitleACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis-induced macrophage death.
Publication TypeJournal Article
Year of Publication2025
AuthorsYang Z, Zhang L, Ottavi S, Geri JB, Perkowski A, Jiang X, Pfau D, Bryk R, Aubé J, Zimmerman M, Dartois V, Nathan C
JournalProc Natl Acad Sci U S A
Volume122
Issue12
Paginatione2425309122
Date Published2025 Mar 25
ISSN1091-6490
KeywordsAnimals, Carboxy-Lyases, Cell Death, HSP70 Heat-Shock Proteins, Humans, Intracellular Membranes, Lysosomes, Macrophages, Mice, Mice, Inbred C57BL, Mycobacterium tuberculosis, Permeability, Tuberculosis
Abstract

Mycobacterium tuberculosis (Mtb) primarily infects macrophages. In vitro without antibiotics, wild-type Mtb hastens death of the macrophages, but the processes leading to rapid cell death are not well understood. Our earlier work indicated that the death of Mtb-infected mouse macrophages in vitro is markedly exacerbated by induction of interferon-β (IFN-β) [L. Zhang et al., J. Exp. Med. 18, e20200887 (2021)]. Here, we identified a key downstream response to IFN-β in the context of Mtb infection as the massive induction of cis-aconitate decarboxylase (ACOD1), not only in its canonical subcellular localization in mitochondria but also in the cytosol, where it bound to the lysosome-stabilizing protein HSP70. ACOD1's product, itaconate, protected Mtb-infected macrophages. However, the contrasting and predominant effect of high-level ACOD1 expression was to act in a noncatalytic manner to promote HSP70's degradation, leading to lysosomal membrane permeabilization (LMP). Mtb-induced macrophage death was markedly diminished by inhibitors of cysteine proteases, consistent with lysosome-mediated cell death. Neither ACOD1 inhibitors nor cysteine protease inhibitors are suitable for potential host-directed therapy (HDT) of tuberculosis. Instead, this work directs attention to how ACOD1 acts nonenzymatically to promote the degradation of HSP70.

DOI10.1073/pnas.2425309122
Alternate JournalProc Natl Acad Sci U S A
PubMed ID40100622
PubMed Central IDPMC11962489
Grant ListFellowship / / Cancer Research Institute (CRI) /
R21AI178133 / / HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) /
R01 AI155510 / AI / NIAID NIH HHS / United States
ROIAI155510 / / HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) /
R21 AI178133 / AI / NIAID NIH HHS / United States
(no number) / / Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine /

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587